Tits and bits of HIV Tat protein

Bibliography

• Barre-Sinoussi F, Chermann JC, Rey F, Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220(4599):868-71
   PubMed Web of Science ®Google Scholar
• AIDS epidemic update. Geneva, Switzerland: UNAIDS 2009. Available from: http://data.unaids.org/pub/Report/2009/jc1700_epi_update_2009_en.pdf [last accessed 16 December 2010]
   Google Scholar
• Hemelaar J, Gouws E, Ghys PD, Osmanov S. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 2006;20(16):W13-23
   PubMed Web of Science ®Google Scholar
• Kandathil AJ, Ramalingam S, Kannangai R, Molecular epidemiology of HIV. Indian J Med Res 2005;121:333-44
   PubMed Web of Science ®Google Scholar
• Campbell GR, Loret EP. What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine? Retrovirology 2009;6:50
   Google Scholar
• Robertson DL, Anderson JP, Bradac JA, HIV-1 nomenclature proposal. Science 2000;288:55-6
   PubMed Web of Science ®Google Scholar
• Korber B, Gaschen B, Yusim K, Evolutionary and immunological implications of contemporary HIV-1 variation. Br Med Bull 2001;58:19-42
   PubMed Web of Science ®Google Scholar
• van Opijnen T, Jeeninga RE, Boerlijst MC, Human immunodeficiency virus type 1 subtypes have a distinct long terminal repeat that determines the replication rate in a host-cell-specific manner. J Virol 2004;78:3675-83
   PubMed Web of Science ®Google Scholar
• Gottlieb GS, Nickle DC, Jensen MA, Dual HIV-1 infection associated with rapid disease progression. Lancet 2004;363:619-22
   PubMed Web of Science ®Google Scholar
• Osmanov S, Pattou C, Walker N, Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J Acquir Immune Defic Syndr 2002;29:184-90
   PubMed Web of Science ®Google Scholar
• Gilbert PB, McKeague IW, Eisen G, Comparison of HIV-1 and HIV-2 infectivity from a prospective cohort study in Senegal. Stat Med 2003;22:573-93
   PubMed Web of Science ®Google Scholar
• Reeves JD, Doms RW. Human immunodeficiency virus type 2. J Gen Virol 2002;83:1253-65
   PubMed Web of Science ®Google Scholar
• Kuiken C, Foley B, Freed E, HIV sequence compendium 2008. Theoretical Biology and Biophysics Group T-10, Los Aalamos NM; 2008
   Google Scholar
• Frankel AD, Young JA. HIV-1: fifteen proteins and an RNA. Annu Rev Biochem 1998;67:1-25
   PubMed Web of Science ®Google Scholar
• Hu WS, Temin HM. Retroviral recombination and reverse transcription. Science 1990;250:1227-33
   PubMed Web of Science ®Google Scholar
• Nomaguchi M, Adachi A. Accessory proteins of HIV and innate anti-retroviral factors. Uirusu 2009;59:67-74
   PubMedGoogle Scholar
• Jeang KT, Xiao H, Rich EA. Multifaceted activities of the HIV-1 transactivator of transcription, Tat. J Biol Chem 1999;274(41):28837-40
   PubMed Web of Science ®Google Scholar
• El Kharroubi A, Piras G, Zensen R, Martin MA. Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter. Mol Cell Biol 1998;18:2535-44
   PubMed Web of Science ®Google Scholar
• Pessler F, Cron RQ. Reciprocal regulation of the nuclear factor of activated T cells and HIV-1. Genes Immun 2004;5:158-67
   PubMed Web of Science ®Google Scholar
• Bres V, Tagami H, Peloponese JM, Differential acetylation of Tat coordinates its interaction with the co-activators cyclin T1 and PCAF. EMBO J 2002;21:6811-19
   PubMedGoogle Scholar
• Li W, Li G, Steiner J, Nath A. Role of Tat protein in HIV neuropathogenesis. Neurotox Res 2009;16:205-20
   PubMed Web of Science ®Google Scholar
• Wong JK, Campbell GR, Spector SA. Differential induction of interleukin-10 in monocytes by HIV-1 Clade B and Clade C Tat proteins. J Biol Chem 2010;285:18319-25
   PubMed Web of Science ®Google Scholar
• Foucault M, Mayol K, Receveur-Brechot V, UV and X-ray structural studies of a 101-residue long Tat protein from a HIV-1 primary isolate and of its mutated, detoxified, vaccine candidate. Proteins 2010;78:1441-56
   PubMed Web of Science ®Google Scholar
• Hetzer C, Dormeyer W, Schnolzer M, Ott M. Decoding Tat: the biology of HIV Tat posttranslational modifications. Microbes Infect 2005;7:1364-9
   PubMed Web of Science ®Google Scholar
• Siddappa NB, Venkatramanan M, Venkatesh P, Transactivation and signaling functions of Tat are not correlated: biological and immunological characterization of HIV-1 subtype-C Tat protein. Retrovirology 2006;3:53
   PubMed Web of Science ®Google Scholar
• Romani B, Engelbrecht S, Glashoff RH. Functions of Tat: the versatile protein of human immunodeficiency virus type 1. J Gen Virol 2010;91:1-12
   PubMed Web of Science ®Google Scholar
• Pumfery A, Deng L, Maddukuri A, Chromatin remodeling and modification during HIV-1 Tat-activated transcription. Curr HIV Res 2003;1:343-62
   PubMed Web of Science ®Google Scholar
• Richman DD, Margolis DM, Delaney M, The challenge of finding a cure for HIV infection. Science 2009;323:1304-7
   PubMed Web of Science ®Google Scholar
• Huigen MC, Kamp W, Nottet HS. Multiple effects of HIV-1 trans-activator protein on the pathogenesis of HIV-1 infection. Eur J Clin Invest 2004;34:57-66
   PubMed Web of Science ®Google Scholar
• Matsui M, Warburton RJ, Cogswell PC, Effects of HIV-1 Tat on expression of HLA class I molecules. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:233-40
   PubMedGoogle Scholar
• Sodroski J, Rosen C, Wong-Staal F, Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat. Science 1985;227(4683):171-3
   PubMed Web of Science ®Google Scholar
• Brady J, Kashanchi F. Tat gets the “green” light on transcription initiation. Retrovirology 2005;2:69
   Google Scholar
• Kao SY, Calman AF, Luciw PA, Peterlin BM. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature 1987;330:489-93
   PubMed Web of Science ®Google Scholar
• Barboric M, Peterlin BM. A new paradigm in eukaryotic biology: HIV Tat and the control of transcriptional elongation. PLoS Biol 2005;3(2):e76
   PubMedGoogle Scholar
• Marshall NF, Peng J, Xie Z, Price DH. Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J Biol Chem 1996;271:27176-83
   PubMed Web of Science ®Google Scholar
• Sims RJ III, Belotserkovskaya R, Reinberg D. Elongation by RNA polymerase II: the short and long of it. Genes Dev 2004;18:2437-68
   PubMed Web of Science ®Google Scholar
• Ping YH, Rana TM. DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation. J Biol Chem 2001;276:12951-8
   PubMed Web of Science ®Google Scholar
• Garber ME, Wei P, Kewal Ramani VN, The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev 1998;12:3512-27
   PubMed Web of Science ®Google Scholar
• Tahirov TH, Babayeva ND, Varzavand K, Crystal structure of HIV-1 Tat complexed with human P-TEFb. Nature 2010;46:747-51
   Google Scholar
• Nickel W, Rabouille C. Mechanisms of regulated unconventional protein secretion. Nat Rev Mol Cell Biol 2009;10:148-55
   PubMed Web of Science ®Google Scholar
• Abrahamsen H, Stenmark H. Protein secretion: unconventional exit by exophagy. Curr Biol 2010;20:R415-18
   Web of Science ®Google Scholar
• Rayne F, Debaisieux S, Yezid H, Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells. EMBO J 2010;29:1348-62
   PubMed Web of Science ®Google Scholar
• Ensoli B, Barillari G, Salahuddin SZ, Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 1990;345:84-6
   PubMed Web of Science ®Google Scholar
• Xiao H, Neuveut C, Tiffany HL, Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc Natl Acad Sci USA 2000;97:11466-71
   PubMed Web of Science ®Google Scholar
• Gallo RC. Tat as one key to HIV-induced immune pathogenesis and Tat (correction of Pat) toxoid as an important component of a vaccine. Proc Natl Acad Sci USA 1999;96:8324-6
   PubMed Web of Science ®Google Scholar
• Darbinian N, Darbinyan A, Czernik M, HIV-1 Tat inhibits NGF-induced Egr-1 transcriptional activity and consequent p35 expression in neural cells. J Cell Physiol 2008;216:128-34
   PubMed Web of Science ®Google Scholar
• Chang HC, Samaniego F, Nair BC, HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS 1997;11:1421-31
   PubMed Web of Science ®Google Scholar
• Rayne F, Debaisieux S, Bonhoure A, Beaumelle B. HIV-1 Tat is unconventionally secreted through the plasma membrane. Cell Biol Int 2010;34:409-13
   PubMed Web of Science ®Google Scholar
• Di Paolo G, De Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature 2006;443:651-7
   PubMed Web of Science ®Google Scholar
• De Matteis MA, Godi A. PI-loting membrane traffic. Nat Cell Biol 2004;6:487-92
   PubMed Web of Science ®Google Scholar
• Vendeville A, Rayne F, Bonhoure A, HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses. Mol Biol Cell 2004;15:2347-60
   PubMed Web of Science ®Google Scholar
• Liu Y, Jones M, Hingtgen CM, Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat Med 2000;6:1380-7
   PubMed Web of Science ®Google Scholar
• Tyagi M, Rusnati M, Presta M, Giacca M. Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem 2001;276:3254-61
   PubMed Web of Science ®Google Scholar
• Watkins JD, Campbell GR, Halimi H, Loret EP. Homonuclear 1H NMR and circular dichroism study of the HIV-1 Tat Eli variant. Retrovirology 2008;5:83
   PubMedGoogle Scholar
• Peloponese JM Jr, Collette Y, Gregoire C, Full peptide synthesis, purification, and characterization of six Tat variants. Differences observed between HIV-1 isolates from Africa and other continents. J Biol Chem 1999;274:11473-8
   PubMed Web of Science ®Google Scholar
• Gregoire C, Peloponese JM Jr, Esquieu D, Homonuclear 1H-NMR assignment and structural characterization of human immunodeficiency virus type 1 Tat Mal protein. Biopolymers 2001;62:324-35
   PubMed Web of Science ®Google Scholar
• Shojania S, O'Neil JD. HIV-1 Tat is a natively unfolded protein: the solution conformation and dynamics of reduced HIV-1 Tat-(1-72) by NMR spectroscopy. J Biol Chem 2006;281:8347-56
   PubMed Web of Science ®Google Scholar
• Yezid H, Konate K, Debaisieux S, Mechanism for HIV-1 Tat insertion into the endosome membrane. J Biol Chem 2009;284:22736-46
   PubMed Web of Science ®Google Scholar
• Garcia JA, Harrich D, Pearson L, Functional domains required for tat-induced transcriptional activation of the HIV-1 long terminal repeat. EMBO J 1988;7:3143-7
   PubMed Web of Science ®Google Scholar
• Carroll R, Martarano L, Derse D. Identification of lentivirus tat functional domains through generation of equine infectious anemia virus/human immunodeficiency virus type 1 tat gene chimeras. J Virol 1991;65:3460-7
   PubMed Web of Science ®Google Scholar
• Churcher MJ, Lamont C, Hamy F, High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region. J Mol Biol 1993;230:90-110
   PubMed Web of Science ®Google Scholar
• Hauber J, Malim MH, Cullen BR. Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein. J Virol 1989;63:1181-7
   PubMed Web of Science ®Google Scholar
• de Mareuil J, Carre M, Barbier P, HIV-1 Tat protein enhances microtubule polymerization. Retrovirology 2005;2:5
   PubMedGoogle Scholar
• Barillari G, Gendelman R, Gallo RC, Ensoli B. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc Natl Acad Sci USA 1993;90:7941-5
   PubMed Web of Science ®Google Scholar
• Mahlknecht U, Dichamp I, Varin A, NF-kappaB-dependent control of HIV-1 transcription by the second coding exon of Tat in T cells. J Leukoc Biol 2008;83:718-27
   PubMed Web of Science ®Google Scholar
• Lopez-Huertas MR, Callejas S, Abia D, Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exon. Nucleic Acids Res 2010;38:3287-307
   PubMed Web of Science ®Google Scholar
• Bayer P, Kraft M, Ejchart A, Structural studies of HIV-1 Tat protein. J Mol Biol 1995;247:529-35
   PubMed Web of Science ®Google Scholar
• Koken SE, Greijer AE, Verhoef K, Intracellular analysis of in vitro modified HIV Tat protein. J Biol Chem 1994;269:8366-75
   PubMed Web of Science ®Google Scholar
• Peloponese JM Jr, Gregoire C, Opi S, 1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein. C R Acad Sci III 2000;323:883-94
   PubMed Web of Science ®Google Scholar
• Mann M, Jensen ON. Proteomic analysis of post-translational modifications. Nat Biotechnol 2003;21:255-61
   PubMed Web of Science ®Google Scholar
• Herrmann CH, Rice AP. Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase. Virology 1993;197:601-8
   PubMed Web of Science ®Google Scholar
• Yang X, Herrmann CH, Rice AP. The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function. J Virol 1996;70:4576-84
   PubMedGoogle Scholar
• Endo-Munoz L, Warby T, Harrich D, McMillan NA. Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription. Virol J 2005;2:17
   PubMedGoogle Scholar
• Ammosova T, Berro R, Jerebtsova M, Phosphorylation of HIV-1 Tat by CDK2 in HIV-1 transcription. Retrovirology 2006;3:78
   PubMed Web of Science ®Google Scholar
• Choudhary C, Kumar C, Gnad F, Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 2009;325:834-40
   PubMed Web of Science ®Google Scholar
• Kiernan RE, Vanhulle C, Schiltz L, HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J 1999;18:6106-18
   PubMed Web of Science ®Google Scholar
• Col E, Caron C, Seigneurin-Berny D, The histone acetyltransferase, hGCN5, interacts with and acetylates the HIV transactivator, Tat. J Biol Chem 2001;276:28179-84
   PubMed Web of Science ®Google Scholar
• Dorr A, Kiermer V, Pedal A, Transcriptional synergy between Tat and PCAF is dependent on the binding of acetylated Tat to the PCAF bromodomain. EMBO J 2002;21:2715-23
   PubMed Web of Science ®Google Scholar
• Mujtaba S, He Y, Zeng L, Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain. Mol Cell 2002;9:575-86
   PubMed Web of Science ®Google Scholar
• Pagans S, Pedal A, North BJ, SIRT1 regulates HIV transcription via Tat deacetylation. PLoS Biol 2005;3(2):e41
   PubMedGoogle Scholar
• Amini S, Mameli G, Del Valle L, p73 Interacts with human immunodeficiency virus type 1 Tat in astrocytic cells and prevents its acetylation on lysine 28. Mol Cell Biol 2005;25:8126-38
   PubMed Web of Science ®Google Scholar
• Berro R, Kehn K, de la Fuente C, Acetylated Tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32. J Virol 2006;80:3189-204
   PubMed Web of Science ®Google Scholar
• Boulanger MC, Liang C, Russell RS, Methylation of Tat by PRMT6 regulates human immunodeficiency virus type 1 gene expression. J Virol 2005;79:124-31
   PubMed Web of Science ®Google Scholar
• Xie B, Invernizzi CF, Richard S, Wainberg MA. Arginine methylation of the human immunodeficiency virus type 1 Tat protein by PRMT6 negatively affects Tat interactions with both cyclin T1 and the Tat transactivation region. J Virol 2007;81:4226-34
   PubMed Web of Science ®Google Scholar
• McBride AE, Silver PA. State of the arg: protein methylation at arginine comes of age. Cell 2001;106:5-8
   PubMed Web of Science ®Google Scholar
• Sivakumaran H, van der Horst A, Fulcher AJ, Arginine methylation increases the stability of human immunodeficiency virus type 1 Tat. J Virol 2009;83:11694-703
   PubMed Web of Science ®Google Scholar
• Van Duyne R, Easley R, Wu W, Lysine methylation of HIV-1 Tat regulates transcriptional activity of the viral LTR. Retrovirology 2008;5:40
   PubMed Web of Science ®Google Scholar
• Pagans S, Kauder SE, Kaehlcke K, The cellular lysine methyltransferase Set7/9-KMT7 binds HIV-1 TAR RNA, monomethylates the viral transactivator Tat, and enhances HIV transcription. Cell Host Microbe 2010;7:234-44
   PubMed Web of Science ®Google Scholar
• Conaway RC, Brower CS, Conaway JW. Emerging roles of ubiquitin in transcription regulation. Science 2002;296:1254-8
   PubMed Web of Science ®Google Scholar
• Bres V, Kiernan RE, Linares LK, A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter. Nat Cell Biol 2003;5:754-61
   PubMed Web of Science ®Google Scholar
• Brondyk WH. Selecting an appropriate method for expressing a recombinant protein. Methods Enzymol 2009;463:131-47
   PubMed Web of Science ®Google Scholar
• Sahdev S, Khattar SK, Saini KS. Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategies. Mol Cell Biochem 2008;307:249-64
   PubMed Web of Science ®Google Scholar
• Peng H, Reinhart TA, Retzel EF, Single cell transcript analysis of human immunodeficiency virus gene expression in the transition from latent to productive infection. Virology 1995;206:16-27
   PubMed Web of Science ®Google Scholar
• Zauli G, Davis BR, Re MC, Tat protein stimulates production of transforming growth factor-beta 1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression. Blood 1992;80:3036-43
   PubMed Web of Science ®Google Scholar
• Westendorp MO, Li-Weber M, Frank RW, Krammer PH. Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells. J Virol 1994;68:4177-85
   PubMed Web of Science ®Google Scholar
• Scala G, Ruocco MR, Ambrosino C, The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein. J Exp Med 1994;179:961-71
   PubMed Web of Science ®Google Scholar
• Lotz M, Clark-Lewis I, Ganu V. HIV-1 transactivator protein Tat induces proliferation and TGFbeta expression in human articular chondrocytes. J Cell Biol 1994;124:365-71
   PubMed Web of Science ®Google Scholar
• Purvis SF, Georges DL, Williams TM, Lederman MM. Suppression of interleukin-2 and interleukin-2 receptor expression in Jurkat cells stably expressing the human immunodeficiency virus Tat protein. Cell Immunol 1992;144:32-42
   PubMed Web of Science ®Google Scholar
• Ito M, Ishida T, He L, HIV type 1 Tat protein inhibits interleukin 12 production by human peripheral blood mononuclear cells. AIDS Res Hum Retroviruses 1998;14:845-9
   PubMed Web of Science ®Google Scholar
• Gandhi N, Saiyed Z, Thangavel S, Differential effects of HIV type 1 clade B and clade C Tat protein on expression of proinflammatory and antiinflammatory cytokines by primary monocytes. AIDS Res Hum Retroviruses 2009;25:691-9
   PubMed Web of Science ®Google Scholar
• Gupta S, Boppana R, Mishra GC, HIV-1 Tat suppresses gp120-specific T cell response in IL-10-dependent manner. J Immunol 2008;180:79-88
   PubMed Web of Science ®Google Scholar
• Zagury D, Lachgar A, Chams V, Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. Proc Natl Acad Sci USA 1998;95:3851-6
   PubMed Web of Science ®Google Scholar
• Barton CH, Biggs TE, Mee TR, Mann DA. The human immunodeficiency virus type 1 regulatory protein Tat inhibits interferon-induced iNos activity in a murine macrophage cell line. J Gen Virol 1996;77:1643-7
   PubMed Web of Science ®Google Scholar
• Gougeon ML, Lecoeur H, Dulioust A, Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J Immunol 1996;156:3509-20
   PubMed Web of Science ®Google Scholar
• Nardelli B, Gonzalez CJ, Schechter M, Valentine FT. CD4+ blood lymphocytes are rapidly killed in vitro by contact with autologous human immunodeficiency virus-infected cells. Proc Natl Acad Sci USA 1995;92:7312-6
   PubMed Web of Science ®Google Scholar
• Chen D, Wang M, Zhou S, Zhou Q. HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bcl-2 relative Bim. EMBO J 2002;21:6801-10
   PubMed Web of Science ®Google Scholar
• Zheng L, Yang YD, Lu GC, Salvato MS. Extracellular HIV Tat and Tat cysteine rich peptide increase CCR5 expression in monocytes. J Zhejiang Univ Sci B 2005;6:668-72
   PubMedGoogle Scholar
• Chauhan A, Turchan J, Pocernich C, Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport. J Biol Chem 2003;278:13512-19
   PubMed Web of Science ®Google Scholar
• Nakajima H, Mizuta N, Fujiwara I, Blockade of the Fas/Fas ligand interaction suppresses hepatocyte apoptosis in ischemia-reperfusion rat liver. Apoptosis 2008;13:1013-21
   PubMed Web of Science ®Google Scholar
• Zhang M, Li X, Pang X, Bcl-2 upregulation by HIV-1 Tat during infection of primary human macrophages in culture. J Biomed Sci 2002;9:133-9
   Google Scholar
• Zauli G, Gibellini D. The human immunodeficiency virus type-1 (HIV-1) Tat protein and Bcl-2 gene expression. Leuk Lymphoma 1996;23:551-60
   PubMed Web of Science ®Google Scholar
• Westendorp MO, Frank R, Ochsenbauer C, Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 1995;375:497-500
   PubMed Web of Science ®Google Scholar
• Sarkaria JN, Busby EC, Tibbetts RS, Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res 1999;59:4375-82
   PubMed Web of Science ®Google Scholar
• Albini A, Ferrini S, Benelli R, HIV-1 Tat protein mimicry of chemokines. Proc Natl Acad Sci USA 1998;95:13153-8
   PubMed Web of Science ®Google Scholar
• Brake DA, Debouck C, Biesecker G. Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat. J Cell Biol 1990;111:1275-81
   PubMed Web of Science ®Google Scholar
• Ju SM, Song HY, Lee JA, Extracellular HIV-1 Tat up-regulates expression of matrix metalloproteinase-9 via a MAPK-NF-kappaB dependent pathway in human astrocytes. Exp Mol Med 2009;41:86-93
   PubMed Web of Science ®Google Scholar
• Visentin S, Renzi M, Levi G. Altered outward-rectifying K+ current reveals microglial activation induced by HIV-1 Tat protein. Glia 2001;33:181-90
   PubMed Web of Science ®Google Scholar
• Ensoli B, Fiorelli V, Ensoli F, The preventive phase I trial with the HIV-1 Tat-based vaccine. Vaccine 2009;28:371-8
   PubMed Web of Science ®Google Scholar
• Bellino S, Francavilla V, Longo O, Parallel conduction of the Phase I preventive and therapeutic trials based on the Tat vaccine candidate. Rev Recent Clin Trials 2009;4:195-204
   PubMedGoogle Scholar
• Gavioli R, Cellini S, Castaldello A, The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: implications for the design of new vaccination strategies against AIDS. Vaccine 2008;26:727-37
   PubMed Web of Science ®Google Scholar
• Kittiworakarn J, Lecoq A, Moine G, HIV-1 Tat raises an adjuvant-free humoral immune response controlled by its core region and its ability to form cysteine-mediated oligomers. J Biol Chem 2006;281:3105-15
   PubMed Web of Science ®Google Scholar
• Stehbens WE. Oxidative stress in viral hepatitis and AIDS. Exp Mol Pathol 2004;77:121-32
   PubMed Web of Science ®Google Scholar
• Pande V, Ramos MJ. Nuclear factor kappa B: a potential target for anti-HIV chemotherapy. Curr Med Chem 2003;10:1603-15
   PubMed Web of Science ®Google Scholar
• McCarty MF, Barroso-Aranda J, Contreras F. NADPH oxidase mediates glucolipotoxicity-induced beta cell dysfunction--clinical implications. Med Hypotheses 2010;74:596-600
   PubMed Web of Science ®Google Scholar
• Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature 1996;384:529-34
   PubMed Web of Science ®Google Scholar
• Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765
   PubMed Web of Science ®Google Scholar
• Fanales-Belasio E, Moretti S, Fiorelli V, HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection. J Immunol 2009;182:2888-97
   PubMed Web of Science ®Google Scholar
• Ameglio F, Cordiali Fei P, Solmone M, Serum IL-10 levels in HIV-positive subjects: correlation with CDC stages. J Biol Regul Homeost Agents 1994;8:48-52
   PubMed Web of Science ®Google Scholar
• Nunnari G, Smith JA, Daniel R. HIV-1 Tat and AIDS-associated cancer: targeting the cellular anti-cancer barrier? J Exp Clin Cancer Res 2008;27:3
   PubMedGoogle Scholar
• Srivastava DK, Tendler CL, Milani D, The HIV-1 transactivator protein Tat is a potent inducer of the human DNA repair enzyme beta-polymerase. AIDS 2001;15:433-40
   PubMed Web of Science ®Google Scholar
• Chipitsyna G, Slonina D, Siddiqui K, HIV-1 Tat increases cell survival in response to cisplatin by stimulating Rad51 gene expression. Oncogene 2004;23:2664-71
   PubMed Web of Science ®Google Scholar
• Li CJ, Wang C, Friedman DJ, Pardee AB. Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1995;92:5461-4
   PubMed Web of Science ®Google Scholar
• Vene R, Benelli R, Noonan DM, Albini A. HIV-Tat dependent chemotaxis and invasion, key aspects of tat mediated pathogenesis. Clin Exp Metastasis 2000;18:533-8
   PubMed Web of Science ®Google Scholar
• Stettner MR, Nance JA, Wright CA, SMAD proteins of oligodendroglial cells regulate transcription of JC virus early and late genes coordinately with the Tat protein of human immunodeficiency virus type 1. J Gen Virol 2009;90:2005-14
   PubMed Web of Science ®Google Scholar
• Aoki Y, Tosato G. HIV-1 Tat enhances Kaposi sarcoma-associated herpesvirus (KSHV) infectivity. Blood 2004;104:810-14
   PubMed Web of Science ®Google Scholar
• Aoki Y, Tosato G. Targeted inhibition of angiogenic factors in AIDS-related disorders. Curr Drug Targets Infect Disord 2003;3:115-28
   PubMedGoogle Scholar
• Guo HG, Pati S, Sadowska M, Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immunodeficiency virus type 1 Tat. J Virol 2004;78:9336-42
   PubMed Web of Science ®Google Scholar
• Chen X, Cheng L, Jia X, Human immunodeficiency virus type 1 Tat accelerates Kaposi sarcoma-associated herpesvirus Kaposin A-mediated tumorigenesis of transformed fibroblasts in vitro as well as in nude and immunocompetent mice. Neoplasia 2009;11:1272-84
   PubMed Web of Science ®Google Scholar
• Nyagol J, Leucci E, Onnis A, The effects of HIV-1 Tat protein on cell cycle during cervical carcinogenesis. Cancer Biol Ther 2006;5:684-90
   PubMed Web of Science ®Google Scholar
• Tada H, Rappaport J, Lashgari M, Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. Proc Natl Acad Sci USA 1990;87:3479-83
   PubMed Web of Science ®Google Scholar
• Enam S, Sweet TM, Amini S, Evidence for involvement of transforming growth factor beta1 signaling pathway in activation of JC virus in human immunodeficiency virus 1-associated progressive multifocal leukoencephalopathy. Arch Pathol Lab Med 2004;128:282-91
   PubMed Web of Science ®Google Scholar